Solid IO
About
Solid IO is a Helsinki-based medtech startup transforming oncology and immunotherapy with next-generation organ-on-chip technology. It develops a patient-specific tumor-on-chip platform that replicates a patient's tumor and immune environment inside a chip to help develop new immunotherapies faster and more cheaply. Founded in January 2025, it secured roughly EUR 800k in early funding and a EUR 400,000 R&D grant from Business Finland. (Note: batch metadata listed the sector as Infra SaaS, but the identified company is biotech/healthtech.)
Latest news
Checking the news desk for fresh coverage…
Coverage gathered from public sources.
Why Deeptech
Selective, conviction-led bets at the frontier - quantum, climate and next-generation digital infrastructure - where a technical edge compounds.